Back to Awarded Treatment Trials
Awarded Trial: 97-RC-301-5
Grant ID
97-RC-301-5
Illness
Bipolar Disorder
Primary Drug/Intervention
Aripiprazole
Primary Dosage
N/A
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Findling
Sample Size
60
Duration of Study Period for Each Subject
16 weeks
Outcome Measurements
N/A
Results
Patients meeting entry criteria will be treated with open label APZ for up to 16 weeks. Sixty patients that achieve syndromal remission will then receive either ongoing APZ therapy (n=30) or placebo therapy (n=30) for up to 72 weeks. Youths who relapse, may then be treated for 8-weeks with open-label APZ.
Publication
N/A
Link
N/A
PI Name
Robert Findling
Degree
MD
Center
Case Western Reserve University, Child and Adolescent Psychiatry
Institution
University Hospitals of Cleveland
Address
11100 Euclid Avenue
City or Town
Cleveland
State or Province
OH
Zip or Postal Code
44106
Country
USA
Email Address
robert.findling@uhhs.com